From treating events to preventing them
The disease behind most heart attacks, atherosclerosis, is not sudden at all. It is a slow accumulation of plaque within the artery walls that begins surprisingly early in life, often decades before it causes any symptom. By the time it announces itself, it has usually been developing in silence for a very long time.
This is the insight that drives preventative cardiology. If the disease takes decades to build, then the decades are precisely where the opportunity lies. Waiting for symptoms means waiting until much of the damage is done. Acting early means acting while the process is still slow, still modest, and still highly responsive to change.
The shift is from reaction to anticipation. Rather than asking whether someone is having a cardiac problem now, preventative cardiology asks where their heart is heading over the next thirty years, and what can be done today to change that trajectory. It is, in the truest sense, medicine practised in the future tense.
Why the standard risk score falls short
For decades, cardiac risk has been estimated using calculators that combine a handful of familiar factors: age, blood pressure, cholesterol, smoking and diabetes. These tools have value, and they remain a sensible starting point. But they have a significant blind spot.
Most calculate risk over the next ten years. For an older person, that window captures much of what matters. For a younger or middle-aged person whose disease is slowly building but whose ten-year risk still appears low, it can be falsely reassuring. The very people with the most to gain from early action are often the ones these scores overlook.
They also miss a great deal. A standard score cannot see the inherited risk carried in certain blood markers, the early plaque already forming in the arteries, or the metabolic and inflammatory drivers that do not appear on the form. Preventative cardiology exists to look where the ordinary calculator cannot, and to replace a population estimate with a picture of the individual.
Reading the blood more precisely
The first step beyond the standard score is to read the blood more carefully. Conventional cholesterol testing measures the amount of cholesterol carried in the blood. More advanced markers measure something more telling: the number and type of particles doing the carrying.
One such marker counts the atherogenic particles directly, the particles capable of lodging in an artery wall and beginning the process of plaque. Because risk relates to how many of these particles there are, this can reveal danger that a standard cholesterol result misses entirely. Another marker reflects an inherited, largely genetic form of risk that conventional tests do not capture at all, and which, once known, changes how aggressively prevention should be pursued. Around these sit markers of inflammation and of metabolic health, the conditions in which heart disease either accelerates or is held back.
Read together, these turn a blurred picture into a sharp one. They explain why some people with seemingly normal cholesterol suffer heart attacks, and why others with alarming numbers do not. The aim is not more testing for its own sake, but a truer measure of the risk that is actually present.
Seeing the arteries themselves
The most powerful advance in preventative cardiology is the ability to move beyond estimating risk and to look directly at the arteries, to see whether disease is present rather than merely calculating how likely it is.
The calcium score
A coronary artery calcium score uses a quick, low-dose CT scan to detect calcified plaque in the heart's arteries. Because such calcium does not appear in healthy arteries, it is a direct sign of established disease, and the score reflects how much has accumulated. A score of zero is strongly reassuring for the years ahead, while a higher score signals a burden of disease that warrants serious, early attention. It is one of the most useful tools available for reclassifying a person's risk, often revealing more than any calculator.
Coronary CT angiography
Where a fuller picture is needed, coronary CT angiography uses high-resolution imaging to visualise the arteries in detail, showing not only calcified plaque but the softer, earlier plaque that a calcium score cannot detect, along with any narrowing of the vessels. It allows a cardiologist to see the actual state of the coronary arteries, and increasingly to characterise the nature of the plaque present, rather than infer it.
Together, these turn cardiac risk from a probability into an observation. They answer the question that matters most: not how likely is disease, but is it here, and how far has it progressed.
From risk to regression
The reason all of this matters is what it makes possible. When disease is found early, while it is still modest, the response can be early too, and the results can be remarkable.
The same process that builds plaque can, with the right intervention, be slowed, halted, and in some cases partially reversed. Aggressive management of the markers that drive it, careful lowering of the harmful particles, optimisation of blood pressure, attention to the metabolic and inflammatory conditions in which disease thrives, and the foundational power of exercise and nutrition, can change the trajectory of an artery. Imaging then allows that change to be measured, turning prevention from an act of faith into something that can be tracked and confirmed.
This is the deeper promise of the field. A heart attack prevented leaves no mark and tells no story, which is exactly why this work goes largely unseen. But it is, in the end, the most valuable cardiology of all: the kind that ensures the crisis never arrives.
What these assessments cannot do
Honesty about limits is part of doing this well. These are powerful tools, but they are not magic, and they are not for everyone in every form.
A calcium score detects only calcified plaque, which forms relatively late, so a low score does not entirely exclude early, softer disease. Detailed imaging involves a careful weighing of its benefit against considerations such as radiation and contrast, and is not something to be undertaken indiscriminately. None of these assessments replaces the fundamentals, because no scan undoes the effects of poor sleep, inactivity or an unhealthy diet. And every result requires interpretation by a cardiologist in the full context of the individual, because a number without judgement can mislead as easily as it informs.
Used wisely, by the right clinician, for the right person, these assessments are transformative. Used indiscriminately, they can create anxiety and overtreatment. The skill lies in knowing what to measure, in whom, and what to do with the answer.
The Lifecore difference
At Lifecore, the heart is assessed by a cardiologist with the explicit aim of acting early. Our cardiac evaluation draws on advanced blood markers, ultrahigh-resolution CT coronary angiography, high-resolution cardiac CT and MRI with perfusion imaging, cardiopulmonary exercise testing and ambulatory monitoring, so that risk is not estimated from a form but observed in the individual.
These findings are read alongside the rest of your diagnostic picture, your metabolism, your biological age, your fitness and your inflammatory status, because the heart cannot be understood in isolation. And where disease is found, the goal is unambiguous: to intervene early enough to slow its progression, and where possible to encourage its regression, then to measure the result over time. This is preventative cardiology as it should be practised, decades ahead of the diagnosis, and firmly on your side.
How to tell whether your heart is being assessed for prevention
Standard cardiac care often begins only once there is a problem. Preventative cardiology is recognisable in how it works. When considering any assessment, it is worth asking:
Does it look beyond a standard ten-year risk score to your longer-term, individual risk?
Are advanced blood markers used, beyond conventional cholesterol alone?
Where appropriate, are your arteries assessed directly through imaging, rather than risk only being estimated?
Are the results interpreted by a cardiologist in the full context of your wider health?
Does what is found lead to early, personalised action, with progress measured over time?
If the answer is yes, your heart is being cared for preventatively. If the focus is only on symptoms you do not yet have, the opportunity of the early decades is being missed.
Common questions about preventative cardiology
It is the practice of identifying and reducing the risk of heart disease long before it causes symptoms or a cardiac event. Because the disease behind most heart attacks develops silently over decades, preventative cardiology focuses on finding and addressing it early, while the process is still slow and highly responsive to change.
They are a reasonable starting point but have real blind spots. Standard risk scores often estimate only the next ten years, which can falsely reassure younger people whose disease is slowly building. Conventional cholesterol testing also misses more precise markers and cannot see plaque already forming in the arteries. Preventative cardiology looks where these tools cannot.
It is a quick, low-dose CT scan that detects calcified plaque in the heart's arteries. Because calcium does not appear in healthy arteries, the score is a direct measure of established disease. A score of zero is strongly reassuring, while a higher score indicates a burden of disease that warrants early, serious attention. It does not, however, detect the earliest, softer plaque, which is why it is sometimes combined with more detailed imaging.
The underlying process can often be slowed, halted, and in some cases partially reversed when it is caught early and treated properly. Aggressive management of the markers that drive it, alongside exercise, nutrition and optimisation of blood pressure and metabolic health, can change the course of an artery. Imaging allows this progress to be measured. The earlier the start, the greater the opportunity.
These assessments are powerful but are not for everyone in every form. Imaging involves weighing its benefit against considerations such as radiation and contrast, and is best used selectively, for the right person, at the right time. The decision should always be made with a cardiologist, who determines which assessments are genuinely useful for you rather than applying them indiscriminately.
Because the disease begins decades before symptoms, the value of assessment often comes earlier than people expect, particularly for those with a family history or other risk factors. There is no single right age, but the principle is that the earlier risk is understood, the more can be done about it. A cardiologist can advise on the right approach for your circumstances.